Liezl Gambe

Innoviz Technologies (NASDAQ:INVZ) reported a decline in first-quarter revenue for 2026 due to shifts in project milestones, but the manufacturer maintained its full-year financial outlook as it begins a strategic diversification into the defense and homeland security sectors.

Ondas Holdings (NASDAQ:ONDS) reported blockbuster first-quarter 2026 financial results on Thursday, blowing past the high end of Wall Street and management forecasts.

Healthcare Triangle (NASDAQ:HCTI) reported explosive top-line growth and a massive expansion in gross profit for the first quarter of 2026.

Forgent Power Solutions (NYSE:FPS) reported explosive growth for its fiscal third quarter on Thursday, as the surge in AI data center construction and power grid modernization sent its bookings and backlog to all-time highs.

Editas Medicine (NASDAQ:EDIT) presented compelling new data on its lead in vivo gene-editing candidate, EDIT-401, demonstrating its potential as a durable, one-time treatment for hyperlipidemia.

Binance has announced another token cleanup after confirming that 20 cryptocurrencies will be removed from its Alpha platform.

Canadian Solar (NASDAQ:CSIQ) reported first-quarter revenue that reached the upper limit of its guidance, bolstered by a significant tariff refund and record-setting growth in its battery storage division.

Investors withdrew approximately $635 million from US-listed spot Bitcoin exchange-traded funds on Wednesday, marking the largest single-day net outflow since January 29 and signalling weakening momentum in one of the market’s most closely watched institutional demand indicators.

Argenica Therapeutics (ASX:AGN) has formed a Clinical Advisory Committee to lead its Phase 2b trial for the neuroprotective candidate, ARG-007.

Bitcoin dropped below the key $80,000 level during Asian trading hours as stronger-than-expected US inflation data and geopolitical tensions surrounding Taiwan pressured risk assets globally.